false 0001435064 0001435064 2024-05-16 2024-05-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): May 16, 2024

 

 

Cemtrex Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-37464   30-0399914

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

276 Greenpoint Ave Bld. 8 Suite 208

Brooklyn, NY

  11222
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (631) 756-9116

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol   Name of each exchange on which registered
Common Stock   CETX   Nasdaq Capital Market

 

 

 

 

 

 

CURRENT REPORT ON FORM 8-K

 

Cemtrex, Inc.

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On May 16, 2024, the Annual Meeting of Shareholders (the “Annual Meeting”) of Cemtrex Inc. (“Centrex” or the “Company”) was held. For more information about the proposals set forth, please see the Company’s 2023 Proxy Statement. On the record date of March 18, 2024, there were 1,055,636 shares of the Company’s common stock issued, outstanding and entitled to vote, 4,544,004 votes of the Company’s Series 1 Preferred Stock, and 10,566,916 votes of the Company’s Series C Preferred Stock held by Saagar Govil, CEO and Chairman of the Board of Directors of the Company, for a total of 16,166,566 voting shares. At the Annual Meeting, a total of 14,016,827 voting shares (for a quorum of 86.7%) were represented in person or by proxy at the meeting. Set forth below are the final voting results for the proposals voted on at the Annual Meeting.

 

Proposal 1 – Voting to elect four nominees to the Company’s Board of Directors (the “Board”) for a one-year term expiring at the next Annual Meeting of Shareholders, or until their successors are elected and qualified:

 

   Number of Votes 
Nominee  For   Abstain   Broker Non-Votes 
Saagar Govil   12,247,618    519,657    1,249,552 
Brian Kwon   12,578,860    188,471    1,249,496 
Manpreet Singh   12,551,450    215,923    1,249,454 
Mitodi Filipov   12,571,139    196,186    1,249,502 

 

Each nominee was elected by the Company’s shareholders, consistent with the recommendation from the Board.

 

Proposal 2 - Ratification of the Appointment of the Company’s Independent registered public accounting firm: Voting to ratify Grassi Co. Certified Public Accountants as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2024:

 

For: 13,941,365
Against: 36,602
Abstain; 38,860

 

Proposal 2 was approved by the Company’s shareholders, consistent with the recommendation from the Board.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

Exhibit Number   Exhibit Title
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

2
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CEMTREX, INC.
   
Date: May 16, 2024 By: /s/ Saagar Govil
    Saagar Govil
    Chairman, President and Chief Executive Officer

 

3